CAS RN: 17696-69-4
HEMATOPORPHYRIN DIHYDROCHLORIDE
Product Availability
Choose a grade to view its available package options.
1 package records 1 with current stock 1 grade group
Grade
90% (1)
In stock only
Batch No. Package Availability Warehouse Inquiry
Batchno.20251113
100mg / 250mg / 1g
Confirm by inquiry
Shanghai, Hebei Inquiry
GET A QUOTE
This product has historical factory records. Recorded pack sizes and purity can be used as a supply reference, while project-specific availability is confirmed by inquiry.
Pack sizes on record: 1g
Available purity: ≥95%
Inventory rows with stock: 0
Bulk packaging: confirmed by inquiry
Request Bulk Quote
Recorded sizes, purity and stock details for CAS 17696-69-4
Pack Size
Recorded Purity
Available Qty
Ship From
Inquiry
1g
≥95%
0
Out of Stock
Beijing
Inquiry
17696-69-4 / 3-[18-(2-carboxyethyl)-8,13-bis(1-hydroxyethyl)-3,7,12,17-tetramethyl-22,23-dihydroporphyrin-2-yl]propanoic acid;dihydrochloride
Standard CAS: 17696-69-4
Multi CAS: No
Basic Information
copy
CAS
17696-69-4 copy
Multi CAS
No copy
Molecular Formula
C34H40Cl2N4O6 copy
Molecular Weight
671.600000 copy
Exact Mass
670.232490 copy
SMILES
CC1=C(C2=CC3=NC(=CC4=NC(=CC5=C(C(=C(N5)C=C1N2)C(C)O)C)C(=C4CCC(=O)O)C)C(=C3C)CCC(=O)O)C(C)O.Cl.Cl copy
InChI
InChI=1S/C34H38N4O6.2ClH/c1-15-21(7-9-31(41)42)27-14-28-22(8-10-32(43)44)16(2)24(36-28)12-29-34(20(6)40)18(4)26(38-29)13-30-33(19(5)39)17(3)25(37-30)11-23(15)35-27;;/h11-14,19-20,37-40H,7-10H2,1-6H3,(H,41,42)(H,43,44);2*1H copy
InChIKey
WZQQOXSHARXAID-UHFFFAOYSA-N copy
Computed Properties
copy
Structural Parameters
Heavy atom count
46 copy
Aromatic heavy atom count
20 copy
Fraction Csp3
0.35 copy
Rotatable bonds
8 copy
H-bond acceptors
6 copy
H-bond donors
6 copy
Molar refractivity
184.95 copy
TPSA
172.42 copy
LogP / Solubility
WLOGP
7.47 copy
MLOGP
6.63 copy
XLogP3
7.47 copy
Consensus LogP
7.19 copy
Log S (ESOL)
-8.51 copy
Class (ESOL)
Insoluble copy
Log S (Ali)
-10.46 copy
Class (Ali)
Insoluble copy
Log S (SILICOS-IT)
-11.19 copy
Class (SILICOS-IT)
Insoluble copy
ADME
GI absorption
Low copy
BBB permeant
No copy
P-gp substrate
Yes copy
CYP1A2 inhibitor
No copy
CYP2C19 inhibitor
Yes copy
CYP2C9 inhibitor
No copy
CYP2D6 inhibitor
No copy
CYP3A4 inhibitor
Yes copy
Log Kp (skin permeation)
-1.51 copy
Drug-likeness / Medicinal Chemistry
Lipinski
No copy
Ghose
No copy
Veber
No copy
Egan
No copy
Muegge
No copy
Bioavailability score
0.17 copy
Leadlikeness
No copy
Synthetic Accessibility
10 copy
Safety & Transport
copy
GHS Hazard Statements
Not Classified
Reported as not meeting GHS hazard criteria by 2 of 2 companies. For more detailed information, please visit ECHA C&L website. copy